CytomX Therapeutics Inc (CTMX)
4.43
-0.07
(-1.56%)
USD |
NASDAQ |
May 03, 16:00
4.69
+0.26
(+5.87%)
After-Hours: 20:00
CytomX Therapeutics Cash from Investing (Quarterly): 12.87M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 12.87M |
| September 30, 2023 | -42.94M |
| June 30, 2023 | 26.04M |
| March 31, 2023 | -146.64M |
| December 31, 2022 | 99.82M |
| September 30, 2022 | -0.41M |
| June 30, 2022 | -0.412M |
| March 31, 2022 | -0.736M |
| December 31, 2021 | -0.245M |
| September 30, 2021 | 9.734M |
| June 30, 2021 | -46.01M |
| March 31, 2021 | 59.01M |
| December 31, 2020 | 19.46M |
| September 30, 2020 | -90.07M |
| June 30, 2020 | 49.45M |
| March 31, 2020 | 2.441M |
| December 31, 2019 | 52.86M |
| September 30, 2019 | 38.51M |
| Date | Value |
|---|---|
| June 30, 2019 | 6.94M |
| March 31, 2019 | -18.61M |
| December 31, 2018 | 15.84M |
| September 30, 2018 | -3.18M |
| June 30, 2018 | 16.65M |
| March 31, 2018 | -23.38M |
| December 31, 2017 | -149.76M |
| September 30, 2017 | 15.94M |
| June 30, 2017 | 13.34M |
| March 31, 2017 | -0.788M |
| December 31, 2016 | 42.45M |
| September 30, 2016 | 11.31M |
| June 30, 2016 | -21.48M |
| March 31, 2016 | 13.58M |
| December 31, 2015 | -50.85M |
| September 30, 2015 | 1.297M |
| June 30, 2015 | -28.97M |
| March 31, 2015 | -52.04M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-146.64M
Minimum
Mar 2023
99.82M
Maximum
Dec 2022
2.614M
Average
6.94M
Median
Jun 2019
Cash from Investing (Quarterly) Benchmarks
| Ocular Therapeutix Inc | -0.459M |
| Bristol-Myers Squibb Co | -19.62B |
| ACADIA Pharmaceuticals Inc | -0.347M |
| Cytokinetics Inc | -81.41M |
| Calidi Biotherapeutics Inc | -- |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -21.96M |
| Cash from Financing (Quarterly) | 0.244M |
| Free Cash Flow | -56.88M |
| Free Cash Flow Per Share (Quarterly) | -0.2726 |
| Free Cash Flow to Equity (Quarterly) | -22.23M |
| Free Cash Flow to Firm (Quarterly) | -22.23M |
| Free Cash Flow Yield | -17.39% |